Improving treatment retention for pregnant individuals with substance use disorders
Substance Use in Pregnant People - Optimizing Retention in Treatment by Maximizing Opportunities for Management (SUPPORT-MOM)
['FUNDING_OTHER'] · WASHINGTON UNIVERSITY · NIH-11058100
This study is looking for ways to help pregnant people who are dealing with substance use issues stick to their treatment by offering rewards for staying on track, and it aims to see if this approach can improve their health and safety during pregnancy, especially for those from underserved communities.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | WASHINGTON UNIVERSITY (nih funded) |
| Locations | 1 site (SAINT LOUIS, UNITED STATES) |
| Trial ID | NIH-11058100 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing treatment retention for pregnant individuals struggling with substance use disorders (SUD). It aims to implement a strategy called contingency management, which provides incentives for patients to adhere to their treatment plans. By conducting a randomized control trial at the Clinic for Acceptance, Recovery, and Empowerment (CARE) in Pregnancy, the study seeks to evaluate the effectiveness of this approach in reducing maternal morbidity and overdose risk. The research also addresses the impact of social determinants of health on treatment outcomes, particularly for historically marginalized populations.
Who could benefit from this research
Good fit: Ideal candidates for this research are pregnant individuals experiencing substance use disorders who are seeking treatment.
Not a fit: Patients who are not pregnant or those who do not have substance use disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment retention and better health outcomes for pregnant individuals with substance use disorders.
How similar studies have performed: Previous research has shown that contingency management can be effective for tobacco cessation in pregnant populations, but its application for other substance use disorders is less established.
Where this research is happening
SAINT LOUIS, UNITED STATES
- WASHINGTON UNIVERSITY — SAINT LOUIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KELLY, JEANNIE CHEN — WASHINGTON UNIVERSITY
- Study coordinator: KELLY, JEANNIE CHEN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.